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Abstract: Signal amplification by reversible exchange
(SABRE) is shown to allow access to strongly enhanced
1H NMR signals in a range of substrates in aqueous media.
To achieve this outcome, phase-transfer catalysis is ex-
ploited, which leads to less than 1.5106 mol dm3 of
the iridium catalyst in the aqueous phase. These observa-
tions reflect a compelling route to produce a saline-based
hyperpolarized bolus in just a few seconds for subsequent
in vivo MRI monitoring. The new process has been called
catalyst separated hyperpolarization through signal am-
plification by reversible exchange or CASH-SABRE. We il-
lustrate this method for the substrates pyrazine, 5-methyl-
pyrimidine, 4,6-d2-methyl nicotinate, 4,6-d2-nicotinamide
and pyridazine achieving 1H signal gains of approximately
790-, 340-, 3000-, 260- and 380-fold per proton at 9.4 T at
the time point at which phase separation is complete.
NMR is commonly used across a large number of disciplines,
including chemistry and medicine, but is inherently insensitive
because it probes a population difference between states that
are close in energy. This population difference can be in-
creased by employing hyperpolarization techniques, such as
optical pumping, DNP[1] or the use of parahydrogen (p-H2),
[2]
by p-H2 induced polarization (PHIP),
[3] to increase sensitivity.
A form of PHIP, known as signal amplification by reversible
exchange (SABRE),[4] is used here to hyperpolarize a substrate
in just a few seconds. One of the main advantages of SABRE is
that it achieves this result without the incorporation of p-H2
into the substrate. This technique utilizes a suitable catalyst[5]
to reversibly bind both H2 (p-H2) and the substrate to assemble
a species that can transfer spin order at low magnetic fields
from p-H2 into the substrate.
[6]
One important objective of hyperpolarization lies in the area
of magnetic resonance imaging (MRI) for use in medical diag-
nosis.[7] In fact, employing hyperpolarized agents[8] in applica-
tions such as tumor or metabolic-flux imaging, is beginning to
become a reality.[9] The toxicity of the SABRE catalyst, solvent
and substrate need to be minimized, however, before the
SABRE method could be used clinically.
Currently, the best reported catalyst for SABRE is [IrCl(CO-
D)(IMes)] (1),[10] delivering 1H-signal enhancements reaching
about 50% polarization in [D4]MeOH solutions, in which both
catalyst and p-H2 solubility is very high.
[11] Although previous
studies have shown that less toxic [D6]ethanol/D2O mixtures
can be employed, the level of signal gain is typically re-
duced.[12] However, activity is seen in neat D2O even when cat-
alyst activation can be slow in this solvent.[13] Feiters et al. , and
Shi et al. , respectively, prepared a water-soluble catalyst for
use with SABRE but the resulting enhancements in water were
again weak when compared to those in methanol,[13,14] as were
those achieved by heterogeneous catalysis.[15] Here, we dem-
onstrate how the principles of phase-transfer catalysis can be
used to improve the SABRE response in water while simultane-
ously achieving catalyst separation (Scheme 1). A related ap-
proach has been used very successfully with PHIP such that
10% 13C-polarization was achieved.[16]
To develop this method, a sample was prepared by combin-
ing 0.3 mL of a CDCl3 solution that contained 5 mm of 1 with
0.3 mL of a D2O solution containing 20 mm of the hyperpolari-
zation target pyrazine (pz). As the organic and aqueous phases
are immiscible, the lower CDCl3 layer retained the original
orange colour due to the catalyst, whereas the water remained
colourless. When H2 was added on top of the solution, and the
sample shaken to dissolve it, a rapid reaction ensued that led
to the CDCl3 phase becoming deeply red in colour due to the
formation of [Ir(H)2(IMes)(pz)3]Cl. Shaking, however, causes the
two initially distinct phases to emulsify prior to separating over
60 seconds. Once the aqueous phase is separated, it remains
colourless ; thus, these changes are readily discernible optically,
as shown in Scheme 1. We note that chloroform is partially
soluble in water, ultimately reaching a 0.5% level by volume,[17]
although we have assessed it reaching a 0.08% level here 10
seconds after mixing. Given the toxicity of chloroform,[18] an N2
purge would be needed to lower this level in the aqueous
phase if it were to be used clinically because the environmen-
tal protection agencies recommended water quality criteria
specify a limit of 0.07 mgL1.[19]
These changes can be readily assessed by acquiring a series
of 1D projections of the samples 2H-NMR signal along the z-
axis of the tube using well-established gradient echo methods
(Figure 1). When the corresponding 1H image is recorded to
track the weaker pz signal of this sample, the slow separation
Scheme 1. Partitioning of the SABRE catalyst and hyperpolarization target
between the two immiscible phases of chloroform and water allows the
principles of phase-transfer catalysis to be employed in conjunction with p-
H2 to produce high levels of hyperpolarization in the aqueous phase with
essentially no catalyst contamination.
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of the two phases can be assessed, and ultimately a 62.5:37.5
pz partitioning in favour of the CDCl3 phase is seen.
When this biphasic mixture is exposed to a 3 bar pressure of
p-H2, and the sample shaken in the stray field of the magnet
for 10 seconds, SABRE occurs, as shown by a high resolution
1H NMR spectrum recorded immediately after the sample was
inserted in the high-field spectrometer. The resulting hyperpo-
larized pz response shows a 64515 fold signal enhancement
(2% polarization) per proton when compared to that recorded
under Boltzmann conditions for a phase separation time of
zero. We probed the enhanced pz response in a series of 1D
1H-signal intensity projections along the z-axis of the tube as
a function of increasing phase-separation time. These results
reveal that initially the pz signal intensity is slightly weighted
towards the lower end of the tube in which the aqueous
phase dominates (Figure 2).
The level of this response reduces in size with increasing
separation time due to relaxation and we note that complete
phase separation is not seen before relaxation destroys the hy-
perpolarized response in such a sample. As the aim of this
work was to achieve pz hyperpolarization in water without cat-
alyst contamination, rapid phase separation is essential. A fur-
ther series of test samples were therefore prepared to explore
the effect of varying the amount of CDCl3 and D2O, while keep-
ing the total sample volume constant at 0.6 mL. The level of
signal gain proved to increase by 257% on moving from
pure CDCl3 to a 17% loading, but again, full relaxation occurs
before the phase separation is complete.
As saline represents an ideal solvent for in vivo applications,
we repeated these studies using 0.35 mL of D2O doped with
0.16% w/v of NaCl and 0.25 mL of CDCl3. The effect of this
change was dramatic with the resulting signal gain increasing
to 79020 fold (2.5% polarization) per proton after 10 sec-
onds when phase separation is achieved. These results are il-
lustrated in Figure 3, with the hyperpolarized pz signal area in
the organic and aqueous phases having a ratio of 48.8:51.2
after 10 seconds. The retained pz signal gain after 15 seconds
is 400 fold (1.3% polarization), and when the fully relaxed
image was recorded, the ratio of pz in the two phases is about
23:77 respectively, which shows that the salt is beneficial in im-
proving the aqueous pz loading under these conditions. We
used UV monitoring to compare the rate of transfer of pz from
H2O into CHCl3 in the presence (0.16% w/v) and absence of
NaCl and observed an approximate 4-fold increase, which
means the reverse process is also accelerated. Furthermore,
the red colour associated with the catalyst is still selectively re-
tained in the organic phase. This statement was supported by
the fact that UV spectroscopy on the aqueous phase revealed
that its concentration was less than 1.5106 mol dm3 after
10 seconds, in agreement with the failure to see a SABRE re-
sponse when this layer was tested. Hence, we conclude that
we have established a rapid route to produce a hyperpolarized
bolus in D2O that is essentially catalyst-free in which adding
salt plays a beneficial role.[20] We note that CDCl3 contaminates
Figure 1. 2H signal intensity profiles derived from the solvent response as
a function of distance from the bottom of the NMR tube (right). (a) Prior to
shaking the separated 0.3 mL of a CDCl3 containing 5 mm of 1 and the
0.3 mL of D2O containing 20 mm pz, (b) immediately after shaking an emul-
sion with no formal phase separation evident and (c) 25 seconds later when
partial phase separation is evident.
Figure 2. 1H NMR signal intensity as a function of distance from the bottom
of the NMR tube that results after emulsion-based SABRE-derived phase-
transfer catalysis to produce a hyperpolarized pz response. The fall in pz
signal intensity as a function of time (s), reveals that the hyperpolarized re-
sponse decays before phase-separation is achieved.
Figure 3. 1H NMR signal intensity as a function of distance from the bottom
of the NMR tube that results after SABRE-derived phase-transfer catalysis in
the presence of NaCl. In this case, phase-separation occurs significantly
faster than the relaxation of the hyperpolarized pz response.
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the aqueous phase at a 0.08% level (5 mgL1), which is re-
duced to 0.06% by NaCl at this point.
To show that it is possible to exploit this behaviour in the
collection of MRI data, we replaced the 5 mm NMR tube with
a 10 mm sample and used a triple axis gradient system to ac-
quire 2D one-shot images of slices parallel to the main axis of
the tube (Figure 4). We also measured single voxel spectra
(SVS) of pz in CDCl3 and D2O, which confirm the origin of
these signals as the hyperpolarized agent, distributed between
the organic and aqueous phases (see the Supporting Informa-
tion). The hyperpolarized responses presented in Figure 4 were
recorded 15 seconds after completion of the initial hyperpolari-
zation step.
As a result of recently published results that showed a high
pH dependence to SABRE efficiency,[21] we also tested the ef-
fects of adding the salts, that is, NaCO2Me, NH4CO2Me, NH4Cl,
NaOH, NaH(CO3) and Na2CO3. These results are described in
the Supporting Information and reveal that under spectroscop-
ic examination, separate signals for pz can be seen in the two
distinct phases in the majority of cases. This point confirms
a role for phase transfer without the need for imaging. NaCl,
however, proved to deliver the best separation times and en-
hancement levels.
Considering recent 15N-NMR developments,[22] we have also
demonstrated that when the high-resolution 13C and 15N re-
sponses of pz at a 100 mm concentration are examined, strong
signals are detected in the aqueous and chloroform phases at
different frequencies (Figure 5, 180- and 3000-fold enhance-
ments, respectively). Furthermore, because there is a wide in-
terest in diversifying the range of agents hyperpolarized by
SABRE,[23] we then tested the generality of this approach by
reference to the substrates 5-methylpyrimidine, 4,6-d2-methyl
nicotinate, 4,6-d2-nicotinamide and pyridazine. All four agents
produced SABRE-enhanced resonances in the aqueous phase,
coupled with phase separation times of less than 10 seconds
and good catalyst separation (signal gains of approximately
340, 3000, 260 and 380-fold, respectively under similar condi-
tions to those used for pz earlier, see the Supporting Informa-
tion).The scale of the 4,6 d2-methyl nicotinate response is par-
ticularly noteworthy, and will reflect its long relaxation time,[11]
whereas the pyridazine MRI data of Figure 4c and d illustrate
how the partitioning between the phases varies with agent, in
this case leading to a very strong aqueous signal.
Hence, we believe that this new and simple catalyst separat-
ed hyperpolarization through signal amplification by reversible
exchange (CASH-SABRE) approach reflects an exciting route to
produce high levels of hyperpolarization in a biocompatible
aqueous medium with very limited catalyst contamination. We
have demonstrated here that 1H, 13C and 15N detection is possi-
ble and are now seeking to develop this approach further
through the introduction of chloroform-optimized catalysts
and new substrates, while simultaneously exploring new sol-
vent combinations to further minimize contamination of the
aqueous phase.
Acknowledgements
The Wellcome Trust (092506 and 098335), and the University
of York are thanked for supporting this work. We thank Dr.
Peter Rayner for scientific discussions and providing the 4,6-d2-
methyl nicotinate and 4,6-d2-nicotinamide used in this study.
NMR data can be found via: DOI: 10.15124/5e44a9c2-c968-
42c9-b8f0-885a552bafa0.
Conflict of interest
The authors declare no conflict of interest.
Keywords: hyperpolarization · NMR spectroscopy · para-
hydrogen · SABRE
Figure 4. 2D-1H-MRI images of slices parallel to the Bo field encoding pz
(100 mm) and pyridazine (50 mm) responses under hyperpolarized (a and b,
respectively, 15 seconds after mixing) and thermal conditions (c and d, re-
spectively). Partitioning between the separated aqueous (upper) and organic
(lower) phases is clearly visible with the pyridazine response being particu-
larly notable.
Figure 5. (A) SABRE 13C response of pz in the water (blue) and chloroform
(orange) phases after transfer at 30 G. (B) SABRE 15N NMR pz response in the
water (blue) and chloroform (orange) phases after transfer at about 0 G in
a m-metal shield.
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Achieving High Levels of NMR-
Hyperpolarization in Aqueous Media
With Minimal Catalyst Contamination
Using SABRE
Show me the money : Catalyst separat-
ed hyperpolarization through signal am-
plification by reversible exchange or
CASH-SABRE allows access to strongly
enhanced 1H, 13C and 15N NMR signals
for a range of substrates in aqueous
media through phase-transfer catalysis.
Very limited catalyst contamination is
observed and hence a biocompatible
bolus is readily achieved.
Signal amplification by reversible exchange (SABRE) is shown to allow access to
strongly enhanced 1H NMR signals in a range of substrates in aqueous media. To
achieve this outcome, phase-transfer catalysis is exploited, which leads to less than
1.5106 mol dm3 of the iridium catalyst in the aqueous phase. These observations
reflect a compelling route to produce a saline-based hyperpolarized bolus in just
a few seconds for subsequent in vivo MRI monitoring. The new process has been
called catalyst separated hyperpolarization through signal amplification by reversible
exchange or CASH-SABRE. For more details, see the Communication by S. B. Duckett
et al. on page && ff.
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